LEADER 05505nam 2200829Ia 450 001 9910970251803321 005 20250718165240.0 010 $a9786611109943 010 $a9780309178976 010 $a0309178975 010 $a9781281109941 010 $a1281109940 010 $a9780309110112 010 $a0309110114 035 $a(CKB)1000000000481358 035 $a(EBL)3564136 035 $a(SSID)ssj0000237568 035 $a(PQKBManifestationID)11924862 035 $a(PQKBTitleCode)TC0000237568 035 $a(PQKBWorkID)10221730 035 $a(PQKB)10777332 035 $a(MiAaPQ)EBC3564136 035 $a(Au-PeEL)EBL3564136 035 $a(CaPaEBR)ebr10201109 035 $a(CaONFJC)MIL110994 035 $a(OCoLC)932320414 035 $a(Perlego)4736668 035 $a(BIP)14672964 035 $a(EXLCZ)991000000000481358 100 $a20071104d2008 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aReview of the DoD-GEIS influenza programs $estrengthening global surveillance and response /$fCommittee for the Assessment of DoD-GEIS Influenza Surveillance and Response Programs, Board on Global Health, Institute of Medicine of the National Academies 205 $a1st ed. 210 $aWashington, D.C. $cNational Academies Press$dc2008 215 $a1 online resource (xxii, 226 pages) 300 $aDescription based upon print version of record. 311 08$aPrint version: Review of the DoD-GEIS influenza programs. Washington, D.C. : National Academies Press, 2007 0309110106 9780309110105 (OCoLC)180691099 311 08$a9780309110105 311 08$a0309110106 320 $aIncludes bibliographical references. 327 $aIntroduction. -- DoD-GEIS headquarters AI/PI management and support activites. -- Naval Medical Research Unit 2 Indonesia avian and pandemic influenza activities. -- Armed Forces Research Institute of Medical Sciences Thailand avian and pandemic influenza activities. -- Naval Medical Research Unit 3 Egypt avian and pandemic influenza activities. -- Naval Medical Research Center Detachment Peru avian and pandemic influenza activities. -- Naval Medical Research Center San Diego avian and pandemic influenza activities. -- Air Force Institute for Operational Health San Antonio avian and pandemic influenza activities. -- Overarching conclusions and recommendations 330 $aThe influenza pandemics of 1918, 1957, and 1968 offer a warning to the world about the potential dangers of the influenza virus. In 2006, after a series of cases and clusters of the highly pathogenic H5N1 avian virus made clear the threat of a possible pandemic, the U.S. Congress allocated $39 million to the Department of Defense Global Emerging Infections Surveillance and Response System (DoD-GEIS) to increase and improve its worldwide influenza surveillance network through upgrades to its domestic and overseas laboratories' capabilities. An Institute of Medicine (IOM) committee was subsequently formed to evaluate the effectiveness of these laboratory-based programs in relation to the supplemental funding, and the report that follows details the committee's findings. The committee that prepared this report, the Committee for the Assessment of DoD-GEIS Influenza Surveillance and Response Programs, was convened at the request of DoD-GEIS management to evaluate the execution of the fiscal year 2006 supplemental funding for avian influenza/ pandemic influenza (AI/PI) surveillance and response. The committee was tasked with evaluating the DoD-GEIS AI/PI surveillance program for the worth of each funded project's contribution to a comprehensive AI/PI surveillance program; the adequacy of the program in view of the evolving epidemiologic factors; responsiveness to the intent of Congress as expressed in Sec. 748, H.R.1815, Pandemic Avian Flu Preparedness; consistency with the DoD and national plans; and coordination of efforts with CDC, WHO, and local governments. Review of the DoD-GEIS Influenza Programs: Strengthening Global Surveillance and Response reviews the development of conclusions and recommendations with long-term, program-level relevance as well as conclusions and recommendations regarding the improvement of specific DoD-GEIS projects. 606 $aInfluenza$xGovernment policy$zUnited States 606 $aCommunicable diseases$xEpidemiology 606 $aMedical policy 606 $aInfluenza, Human$xprevention & control$3(DNLM)D007251Q000517 606 $aCommunicable Disease Control$xmethods$3(DNLM)D003140Q000379 606 $aHealth Policy$3(DNLM)D006291 606 $aPopulation Surveillance$3(DNLM)D011159 606 $aProgram Evaluation$3(DNLM)D015397 607 $aUnited States 615 0$aInfluenza$xGovernment policy 615 0$aCommunicable diseases$xEpidemiology. 615 0$aMedical policy. 615 12$aInfluenza, Human$xprevention & control. 615 22$aCommunicable Disease Control$xmethods. 615 22$aHealth Policy. 615 22$aPopulation Surveillance. 615 22$aProgram Evaluation. 676 $a614.5 712 02$aInstitute of Medicine (U.S.).$bCommittee for the Assessment of DoD-GEIS Influenza Surveillance and Response Programs. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910970251803321 996 $aReview of the DoD-GEIS influenza programs$94361873 997 $aUNINA